Scoring Algorithm-Based Genomic Testing in Dystonia: A Prospective Validation Study
- PMID: 33949708
- DOI: 10.1002/mds.28614
Scoring Algorithm-Based Genomic Testing in Dystonia: A Prospective Validation Study
Abstract
Background: Despite the established value of genomic testing strategies, practice guidelines for their use do not exist in many indications.
Objectives: We sought to validate a recently introduced scoring algorithm for dystonia, predicting the diagnostic utility of whole-exome sequencing (WES) based on individual phenotypic aspects (age-at-onset, body distribution, presenting comorbidity).
Methods: We prospectively enrolled a set of 209 dystonia-affected families and obtained summary scores (0-5 points) according to the algorithm. Singleton (N = 146), duo (N = 11), and trio (N = 52) WES data were generated to identify genetic diagnoses.
Results: Diagnostic yield was highest (51%) among individuals with a summary score of 5, corresponding to a manifestation of early-onset segmental or generalized dystonia with coexisting non-movement disorder-related neurological symptoms. Sensitivity and specificity at the previously suggested threshold for implementation of WES (3 points) was 96% and 52%, with area under the curve of 0.81.
Conclusions: The algorithm is a useful predictive tool and could be integrated into dystonia routine diagnostic protocols. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.
Keywords: diagnostic yield; dystonia; exome sequencing; prediction; rare disease; scoring algorithm.
© 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.
Similar articles
-
Increased diagnostic yield in complex dystonia through exome sequencing.Parkinsonism Relat Disord. 2020 May;74:50-56. doi: 10.1016/j.parkreldis.2020.04.003. Epub 2020 Apr 20. Parkinsonism Relat Disord. 2020. PMID: 32334381
-
Monogenic variants in dystonia: an exome-wide sequencing study.Lancet Neurol. 2020 Nov;19(11):908-918. doi: 10.1016/S1474-4422(20)30312-4. Lancet Neurol. 2020. PMID: 33098801 Free PMC article.
-
Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.Mov Disord. 2019 Nov;34(11):1602-1613. doi: 10.1002/mds.27828. Epub 2019 Oct 4. Mov Disord. 2019. PMID: 31584223 Free PMC article. Review.
-
Whole exome sequencing and clinical investigation of young onset dystonia: What can we learn?Parkinsonism Relat Disord. 2023 Oct;115:105814. doi: 10.1016/j.parkreldis.2023.105814. Epub 2023 Aug 17. Parkinsonism Relat Disord. 2023. PMID: 37607452
-
A novel diagnostic approach for patients with adult-onset dystonia.J Neurol Neurosurg Psychiatry. 2022 Oct;93(10):1039-1048. doi: 10.1136/jnnp-2021-328120. Epub 2022 Jun 10. J Neurol Neurosurg Psychiatry. 2022. PMID: 35688632 Review.
Cited by
-
Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.Front Neurosci. 2023 Nov 10;17:1282267. doi: 10.3389/fnins.2023.1282267. eCollection 2023. Front Neurosci. 2023. PMID: 38027472 Free PMC article.
-
Untangling neurodevelopmental disorders in the adulthood: a movement disorder is the clue.Orphanet J Rare Dis. 2022 Feb 16;17(1):55. doi: 10.1186/s13023-022-02218-8. Orphanet J Rare Dis. 2022. PMID: 35172867 Free PMC article.
References
-
- Clark MM, Stark Z, Farnaes L, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med 2018;3:16.
-
- Rexach J, Lee H, Martinez-Agosto JA, Nemeth AH, Fogel BL. Clinical application of next-generation sequencing to the practice of neurology. Lancet Neurol 2019;18(5):492-503.
-
- Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet 2017;25(2):176-182.
-
- Sun M, Johnson AK, Nelakuditi V, et al. Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes. Genet Med 2019;21(1):195-206.
-
- Trinh J, Lohmann K, Baumann H, et al. Utility and implications of exome sequencing in early-onset Parkinson's disease. Mov Disord 2019;34(1):133-137.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical